Tempus AI — Changelog

Score movements, news, and incidents for Tempus AI in chronological order. Score-change rows fire when the composite moves by ≥1 point between consecutive scoring runs.

• 2026-06-01T21:28:40.000Z news
  Wolfe Research initiates Tempus AI stock coverage with Peerperform - Investing.com
  Sentiment: neutral
• 2026-06-01T12:30:00.000Z news
  Tempus xH test finds 40% more genomic findings than standard care - Stock Titan
  Sentiment: neutral
• 2026-06-01T09:17:00.000Z news
  Tempus AI, Inc. (TEM) Stock Analysis: Exploring a 33.15% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
  Sentiment: neutral
• 2026-06-01T06:12:00.000Z news
  Tempus AI (TEM) Is Up 9.3% After New FDA-Cleared CDx And AI Oncology Platform Upgrades - Yahoo Finance
  Sentiment: neutral
• 2026-06-01T05:05:00.000Z news
  Short Report: Tempus AI short interest at record high - Yahoo Finance
  Sentiment: neutral
• 2026-05-31T14:03:44.000Z news
  Tempus AI Launches Tempus Preview for Rapid Genetic Insights (TE - GuruFocus
  Sentiment: positive
• 2026-05-31T12:32:24.000Z news
  Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development - The Joplin Globe
  Sentiment: neutral
• 2026-05-31T12:30:00.000Z news
  Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development - Carroll County Mirror-Democrat
  Sentiment: neutral
• 2026-05-30T12:00:00.000Z news
  Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results - Business Wire
  Sentiment: neutral
• 2026-05-30T09:32:17.000Z news
  Tempus AI, Inc. (TEM) Analyst/Investor Day - Slideshow (NASDAQ:TEM) 2026-05-30 - Seeking Alpha
  Sentiment: neutral
• 2026-05-30T05:02:43.000Z news
  How The Tempus AI (TEM) Investment Story Is Shifting As Analysts Rework Their Models - Yahoo Finance
  Sentiment: neutral
• 2026-05-30T01:14:56.000Z news
  Why Tempus AI (TEM) Is Up 9.3% After New FDA CDx Approval And AI Platform Upgrades - simplywall.st
  Sentiment: neutral
• 2026-05-29T19:38:00.000Z news
  Tempus AI scores key FDA approval ahead of cancer confab - Crain's Chicago Business
  Sentiment: neutral
• 2026-05-29T18:06:46.000Z news
  Tempus AI, Inc. Receives Fda Approval for Tumor Only xT CDx Enabling Migration of Its Entire Dna Solid Tumor Portfolio - marketscreener.com
  Sentiment: neutral
• 2026-05-29T16:18:48.000Z news
  Investors Buy Large Volume of Tempus AI Call Options (NASDAQ:TEM) - MarketBeat
  Sentiment: neutral
• 2026-05-29T13:37:03.000Z news
  Tempus AI presents multimodal foundation model results at ASCO - Investing.com
  Sentiment: neutral
• 2026-05-29T13:19:00.000Z news
  Tempus AI Stock Climbs As Pharma, Alzheimer’s Deals Build Momentum - timothysykes.com
  Sentiment: neutral
• 2026-05-29T13:15:00.000Z news
  Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology - Business Wire
  Sentiment: neutral
• 2026-05-29T13:07:19.000Z news
  Tempus AI : Investor Day Presentation - marketscreener.com
  Sentiment: neutral
• 2026-05-29T12:44:30.000Z news
  Tempus AI receives FDA approval for tumor-only genomic test - Investing.com
  Sentiment: neutral